Envision Pharma Group has won Excellence in National or Local Education Meetings/Stand-Alone Events at the 2026 Communiqué Awards in London for its work on the Novartis MPN and CML Leaders Programme 2025, developed in partnership with Novartis UK.
Envision was also a finalist in three other categories:
- Building Fertility-Friendly Workplaces with Ferring Pharmaceuticals, in Excellence in Corporate Communications
- MSL Acceleration: Driving Team Excellence in Field Medical with Novartis, in Excellence in Internal Communications
- Envision 90TEN, in Communiqué Medical Affairs Agency of the Year
The Communiqué Awards recognize excellence in healthcare communications, celebrating work that delivers meaningful impact for patients, healthcare professionals, and the wider healthcare community.
The winning program brought together consultants, specialist nurses, and pharmacists from across the UK to strengthen leadership, encourage collaboration, and support lasting service improvements in rare hematology care.
The judges described the initiative as “thoughtful, highly designed on outcomes and perfectly executed” and praised its ability to translate education into tangible service improvements supported by credible real-world examples.
Kathryn Gray, Global Agency Head, Envision 90TEN, said, “The Communiqué Awards are a chance to celebrate the very best of our industry and the difference great communications can make to healthcare. To come away with a win and three further finalist recognitions is something we’re incredibly proud of. It reflects the talent, energy, and commitment of our teams, as well as the strength of the partnerships we’ve built with our clients. It was wonderful to celebrate this achievement together and to recognize the impact we can create when we combine great people with a shared purpose.”
Envision thanks the Communiqué Awards judges, as well as its partners at Novartis UK, Novartis, and Ferring Pharmaceuticals, and every clinician and colleague whose expertise and commitment made these achievements possible. Congratulations to all of this year’s winners and finalists.
